Cellebrite is the industry’s premier remote mobile device data collection solution
Enterprise Endpoint Intelligence platform unifies remote mobile and computing data collection for the first time in a powerful solution that helps reduce business risk by enhancing enterprise eDiscovery and forensic capabilities
PETAH TIKVAH, Israel, September 29, 2021 / PRNewswire / – Cellebrite DI, Ltd. (NASDAQ: CLBT) (“Cellebrite”), a leader in digital intelligence (DI) solutions for the public and private sectors, today announced the release of remote mobile data collection for Cellebrite Endpoint Inspector, the latest update to its cloud-based remote collection solution for e-discovery and corporate investigations. It is the first solution on the market with the ability to remotely retrieve evidence from iOS and Android mobile devices and Mac and Windows computers.
The introduction of remote data collection on mobile devices is the latest step in Cellebrite’s efforts to meet the growing needs of businesses for corporate investigations, e-discovery and incident response with a Integrated endpoint intelligence solution that enhances their ability to take rapid action against threats with industry. – cutting edge data collection and analysis capabilities that are simple, effective and efficient.
“We focused on simplifying the employee experience collecting data and deployed our domain expertise to design Endpoint Inspector to automate the complexity of the collection process and minimize business interruptions. Said Ken Basore, GM Enterprise Solutions, Cellebrite. “In organizations that deploy Endpoint Inspector, employees no longer need to hand over their devices or spend hours with internal support staff going through complex procedures. We are excited to be able to bring this value to our corporate clients in the life sciences, banking, insurance, and other industries.
The ability to unify data collection from computers and mobile devices has come at a critical time for businesses, with several emerging trends putting pressure on business investigations and the eDiscovery process:
Employees use personal devices for work: A third (33%) of people use a personal device such as a computer or smartphone to make working at home easier. Cellebrite’s new mobile remote collection capability can collect evidence from devices inside or outside an organization’s IT network, ensuring that vital information doesn’t go missing.
Critical communication moves to messaging apps: 73% of employees revealed that they use mobile and consumer messaging apps like WhatsApp for business purposes. Cellebrite’s new mobile remote collection capabilities allow investigators and eDiscovery professionals to collect this information and create a richer, more complete picture of events.
The workforce is increasingly distributed: The rise of remote working has also led to distributed teams scattered across geographies and locations. Cellebrite’s remote solution reduces the time and financial impact of collecting data from these employees, reducing the cost and inconvenience of shipping or messaging devices.
Basore continued, “Corporate investigators are under serious pressure, and now face the added challenge of finding data to support cases of a geographically dispersed hybrid workforce, which uses more. devices and messaging services than ever before for business communications. Today’s announcement underscores the strategic importance of Cellebrite’s cloud capabilities and our commitment to ensuring that enterprise investigators can adapt to a hybrid workforce. “
Cellebrite has introduced safeguards into the solution, including its smart collection feature, which ensures that only information relevant to the investigation is pulled from any device. Employees must provide explicit consent before their data is collected and a record of this permission is automatically created as part of the discovery process for audit purposes.
This new solution is available for purchase immediately. For more information or to request a demonstration of the solution, visit www.cellebrite.com/fr/solutions- entreprise.
Cellebrite’s (Nasdaq: CLBT) mission is to empower its clients to protect and save lives, accelerate justice, and preserve privacy in communities around the world. Cellebrite is the global leader in digital intelligence solutions for the public and private sectors, empowering organizations to master the complexity of legally-sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies in more than 140 countries, Cellebrite’s digital intelligence platform and solutions are transforming the way customers collect, examine, analyze and manage data in the framework of investigations sanctioned by law. To find out more, visit us at www.cellebrite.com and https://investisseurs.cellebrite.com.
Caution Regarding Forward-Looking Statements
This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “forecast”, “intention”. , “” seek “,” target “,” anticipate “,” believe “,” might “,” pursue “,” expect “,” estimate “,” might “,” plan “,” prospect “,” future “and” project “and other similar expressions which predict, project or indicate future events or trends or which are not statements of historical matters. These forward-looking statements include estimated financial information. These forward-looking statements regarding income , the earnings, performance, strategies, outlook and other aspects of Cellebrite’s business are based on current expectations which are subject to risks and uncertainties. A number of factors may be t cause actual results to differ materially from those indicated by these forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to develop technologically advanced solutions and successfully integrate with software solutions used by customers; acceptance of solutions by customers; errors, failures, flaws or bugs in the solutions; failure to maintain the productivity of sales and marketing staff or to hire, integrate and retain additional sales and marketing staff; the impact of the global COVID-19 pandemic; the impact of competition on prices and Cellebrite’s market share; sub-optimal product results due to improper use by customers; Cellebrite’s inability to maintain and improve its reputation and brand; the inaccuracy of Cellebrite’s market opportunity estimates and market growth forecasts; changes to packaging and licensing models that negatively affect the ability to attract or retain customers; the inability to effectively manage future growth; the inability to introduce new solutions and add-ons; issues related to the use of artificial intelligence resulting in reputational harm or liability; the need for additional capital to support the growth of Cellebrite’s business; failure to maintain the security of operations and the integrity of software solutions; the impact of government budgeting cycles and assignments, early termination, audits, investigations, sanctions and penalties; declining government budgets, changes in spending or budget priorities, or delays in awarding contracts; a failure to adequately obtain, maintain, protect and enforce the intellectual property of Cellebrite or the infringement of the intellectual property rights of others; legal or regulatory perceptions or decisions that Cellebrite’s solutions violate privacy rights; the use of solutions by clients in a way that is, or is perceived to be, incompatible with human rights; failure to comply with laws regarding privacy, data protection and security, technology protection, sanctions, export controls and other matters; and other factors, risks and uncertainties set out in the sections entitled “Risk Factors” and “Caution Regarding Forward-Looking Statements” in the Management Proxy Circular / Final Prospectus filed with the SEC on August 5, 2021 and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date they are posted, in this communication or elsewhere. Cellebrite makes no commitment to update its forward-looking statements, whether as a result of new information, future developments or otherwise, if circumstances change, except as otherwise required by securities and other laws. applicable laws.
VP Investor Relations
+972 73 394 8440